Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER studyPierFranco Conte, Valentina Guarneri, Antonio Frassoldati et al.|Annals of Oncology|2018Cited by 157
T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and CancerLucia Mazzotti, Massimiliano Mazza, Claudio Cerchione et al.|International Journal of Molecular Sciences|2022Cited by 54